Skip to content

Leprosy

Ch. 1 of 8
— CH. 1 · INTRODUCTION —

Contents

Leprosy

8 sections
  • In the 1980s, 5.2 million people around the world were living with leprosy. By 2020, that figure had fallen below 200,000. Leprosy, also called Hansen's disease, is a long-term infection caused by the bacterium Mycobacterium leprae, or by a close relative, Mycobacterium lepromatosis. It can damage the nerves, the skin, the eyes and the respiratory tract. It is not highly contagious, and people with leprosy can live with their families and attend school and work. Yet for centuries a diagnosis meant being set apart from everyone else. How does a bacterium that is so hard to catch end up taking feeling, fingers and sight? Where did it come from, and how did animals as unlikely as armadillos and red squirrels end up in its story? Why did fear of it shape laws, faith and whole institutions? And what finally changed, so that a course of pills now cures it?

  • About 30% of people with leprosy suffer nerve damage, and nerves are where the disease does its worst work. The bacteria bind to Schwann cells and can strip nerves of their ability to carry signals, a process called demyelination. The body's own inflammatory response adds to the injury. Small sensory fibers in the skin go first, and the affected area may lose its hair and stop sweating.

    The first visible sign is often a pale or pink patch of skin that may not feel heat or pain. Losing the sense of pain, known as nociception, leads to the disease's most feared outcome. A person who cannot feel a cut or a burn keeps injuring the same hand or foot, and unnoticed wounds become infected. Cartilage is gradually absorbed into the body, and fingers and toes shorten and deform.

    The average incubation period is five years. Symptoms can appear within a year or take 20 years or more. Nerve damage can be reversed when treatment starts early. Delay treatment by several months and the damage becomes permanent.

    Doctors sort the disease by how many bacteria are present. A person with five or fewer pale, numb patches has the paucibacillary form. More than five patches means multibacillary disease. At the mild tuberculoid end of the spectrum, bacteria are scant or absent, and this is the most benign form. At the lepromatous end, bacilli fill the lesions in large numbers, and advanced cases can lose their eyebrows and lashes. The Ridley-Jopling scale describes five gradations along this spectrum.

    A skin patch with definite loss of sensation is the key clue. It separates leprosy from look-alikes such as tinea versicolor. Most diagnoses are made from symptoms alone, without laboratory tests. A diagnosis that arrives when a visible disability is already present counts as late. In countries where leprosy is rare, such as the United States, doctors often do not think of it, and that delay is exactly what lets nerve injury become permanent.

  • Ninety-five percent of the people exposed to Mycobacterium leprae never develop leprosy. The bacterium has low pathogenicity, which means it rarely succeeds in causing disease. Shaking hands or sitting beside someone with leprosy does not spread it. Transmission needs close, extensive contact.

    The likely route is the upper airway. Bacilli in secretions from the nose or a cough are inhaled by another person. Older research pointed to the skin as the main route, but newer work favors the respiratory one. Scientists still cannot say how important the skin and the lining of the nose are as exit routes for the bacteria.

    Leprosy is not passed on through sex, and it does not pass from a mother to her unborn child. Seventy-two hours after a person begins appropriate multidrug therapy, they are considered non-infectious.

    Living with a person who has leprosy raises the risk of illness by 5-8 times compared with the general population. The disease is more common among people living in poverty. Malnutrition, other illnesses and genetic mutations can weaken immune function and add risk. Infection with HIV does not appear to do so.

    Cases often cluster in families, and several genetic variants have been identified. In many exposed people, the immune system clears the bacteria early, before serious symptoms develop. A defect in cell-mediated immunity may leave someone open to illness after exposure. Immune response also shapes which form a person gets. A strong cellular response contains the bacteria, while a weaker one allows large bacterial loads and wide spread through the body. One region of DNA tied to this variability is also involved in Parkinson's disease, which has led to speculation that the two disorders are linked at the biochemical level.

  • In 1971, armadillos were first shown to develop leprosy after being inoculated with M. leprae. Their low body temperature lets their tissues hold enormous numbers of the organisms. Between 15 and 20% of Mexican long-nosed armadillos in the south-central United States carry the bacterium. Their armor makes skin lesions hard to spot, and abrasions around the eyes, nose and feet are the most common signs.

    Genetic typing of armadillo strains suggests they were of human origin for at most a few hundred years. That points to early European explorers of the Americas, from whom armadillos probably picked up the organism by accident. The infection then persisted in the armadillo population. It may be passing back to people, which would make leprosy a zoonotic disease. Humans can acquire it by handling armadillos or eating their meat, though the mechanism is not fully understood.

    Armadillos are also valuable to researchers. They have served as models for studying nerve damage, and their nerve function has been assessed with conduction tests. Meanwhile, many people fear them as dangerous, and in parts of America it has become more common to eat raw or undercooked armadillo, which raises the chance of infection.

    In November 2016, red squirrels in Great Britain, a threatened species there, were found to carry leprosy. Nonhuman primates, including African chimpanzees, sooty mangabeys and cynomolgus macaques, have also been infected naturally. Red squirrel fur was highly prized and intensively traded in the medieval period. That trade has been suggested as a cause of the leprosy epidemic in medieval Europe.

    A pre-Norman skull dug up at Hoxne, in Suffolk, in 2017 carried DNA from a strain of M. leprae that closely matched the strain in modern red squirrels on Brownsea Island. Even so, wild squirrels do not appear to pose a high risk to people. The last known human case of leprosy arising in the United Kingdom was recorded over 200 years ago.

  • At Balathal, in Rajasthan, northwest India, skeletal remains found in 2009 hold the oldest documented evidence of leprosy, dating to the 2nd millennium BC. The discoverers were cautious. If the disease traveled from Africa to India in the 3rd millennium BC, they wrote, more skeletal and molecular evidence would be needed to confirm an African origin.

    A tomb at Akeldama, beside the Old City of Jerusalem, held the shrouded body of a man from the first half of the 1st century. Researchers from the Hebrew University of Jerusalem recovered DNA from the remains and proved the case. In 2005, geneticists using comparative genomics traced the disease from East Africa or the Near East along human migration routes, including routes of trade in goods and slaves. They found four strains of M. leprae, each concentrated in particular regions of the world.

    Then came older strains from Great Chesterford, in southeast England, dating to AD 415-545. They suggest another path for the spread and hint that leprosy may have originated in Western Eurasia. They also show that Europe held more strains at the time than researchers had assumed.

    Written records are harder to read. Early sources such as the Indian Atharvaveda, the Egyptian Ebers Papyrus and passages of the Hebrew Bible are ambiguous. The Indian doctor Sushruta's Compendium describes leprotic symptoms, and it dates to around 600 BC in its original form. Hippocrates may have described symptoms consistent with leprosy in 460 BC. Yet the disease probably did not exist in Greece or the Middle East before the Common Era.

    In Norway in 1873, Gerhard Armauer Hansen identified M. leprae as the cause of the disease. It was one of the first pathogenic bacteria ever identified. The name leprosy itself comes from the Greek lepra, tied to lepis, meaning scale. In 2008 a second cause, M. lepromatosis, was found. DNA studies show it lives mainly in the Americas and was there before Europeans arrived. The disease reached Polynesia late, probably not until the middle of the 19th century.

  • The Hebrew word tsaraath covered far more than one illness. Under the law of Leviticus 14:54-57, it took in any progressive skin condition, along with mold or discoloration on clothing, leather and the walls of houses. The Talmud treats it as lesions or stains linked to ritual impurity. Jewish authorities, past and present, describe it as a spiritual ailment with no direct connection to Hansen's disease. The link comes from translations of the Hebrew text into Greek and the misconceptions that followed.

    All three Synoptic Gospels describe Jesus healing people with leprosy, in Matthew 8:1-4, Mark 1:40-45 and Luke 5:12-16. Leviticus 13:44-46 calls the person unclean but stops short of a moral judgement. Later readers were less restrained. Some early Christians believed God was punishing sinful behavior, and in the 6th century Pope Gregory the Great and Isidore of Seville considered people with the disease to be heretics. In India, skin diseases translated as leprosy appear in the Atharva Veda by 600 BC. The Manusmriti, from 200 BC, forbade contact with those infected and made marriage to such a person punishable.

    In the Eastern Roman Empire, church leaders faced a growing health problem and tried to change how society saw it. Gregory of Nazianzus preached sermons urging Christians to help the afflicted. He condemned anyone who rejected them on the claim that God had sent the disease as punishment. Church leaders also began to say "holy disease" instead of "elephant's disease," suggesting the illness purified people for heaven. No cure was found, but patients could receive palliative care and were never expressly banned from society. In the 12th century, the Constantinople jurist Theodore Balsamon noted that people with leprosy could enter the same churches, cities and assemblies as healthy people.

    In the late 6th century, bishops in France, including at Chalon-sur-Saône, worked to set up permanent places to house and feed people with leprosy. By the 12th and 13th centuries, France alone had nearly 2,000 leprosaria. The rise may reflect growing cities and crusaders returning from the Middle East. The third Lateran Council of 1179 required people with leprosy to have their own priests and churches. A 1346 edict by King Edward expelled them from city limits. They were often made to wear identifying clothing or carry a bell announcing their approach.

    Leprosaria were not prisons. Residents went out to beg for alms to support the house, and they met with their families. The stigma, however, outlasted the sick themselves. Groups in medieval Western Europe, such as the Cagots and the Caquins, faced discrimination justified in part by claims that they descended from lepers.

  • In 1832, Dr. JJ Hjort carried out the first leprosy survey in Norway, laying a basis for epidemiological surveys. Later surveys produced a national registry to track the rate of infection. Norwegian scientists Daniel Cornelius Danielssen and Carl Wilhelm Boeck led early research across Europe, which led to the National Leprosy Research and Treatment Center. They believed the disease was hereditary. That view fed arguments for isolating the infected by sex, to prevent reproduction.

    By the 1860s, leprosy was declining in the Western world, yet authorities still embraced isolation. Their reasons included fear of the disease spreading from the Global South, the efforts of Christian missionaries, and a poor grasp of bacteriology and contagion. English surgeon Henry Vandyke Carter saw isolation in Norway and applied it in British India, with money and logistical help from Protestant missionaries. In 1898 the colonial government there passed the Leprosy Act, which forced people with leprosy into asylums, separated by sex. The act proved hard to enforce, and India repealed it in 1983.

    The National Leprosarium at Carville, Louisiana, was the only leprosy hospital in the mainland United States. Patients from across the country were sent there, away from the public. Carville became known for innovations in reconstructive surgery. In 1941-22 patients there took part in trials of a new drug called Promin. The results were described as miraculous.

    Before that, leprosy was believed to be highly contagious and was treated with mercury. For centuries, chaulmoogra tree oil was applied to the skin. Swallowed, it caused nausea, and injected, it formed an abscess. In 1915, Alice Ball discovered how to make the oil water-soluble, and patients improved markedly. Promin was followed by dapsone in the 1950s, then clofazimine and rifampicin in the 1960s and 1970s. When bacteria began to resist dapsone in the 1960s, recorded cases ran to tens of millions.

    The Indian scientist Shantaram Yawalkar and his colleagues combined rifampicin and dapsone to curb resistance. In 1981, the World Health Organization first recommended all three drugs together. Until multidrug therapy arrived in the early 1980s, leprosy could not be diagnosed and treated successfully within the community. The regimen runs six months for paucibacillary disease and 12 months for multibacillary disease. It comes in calendar-labelled blister packs, which makes it easy to use in the field. Rifampicin is given monthly because it speeds up the body's breakdown of dapsone.

    Between 1995 and 1999, the WHO, with the Nippon Foundation, supplied free multidrug therapy to every endemic country. Donations from the manufacturer Novartis later extended the free supply in 2000, 2005-2010 and 2015. For people living with a patient, a single dose of rifampicin is associated with a 57% reduction in infections within 2 years. A vaccine called LepVax entered clinical trials in 2017, with results from 24 participants published in 2020. If it succeeds, it would be the first vaccine made specifically for leprosy.

  • Josefina Guerrero, a Filipino spy in the Second World War, turned fear into cover. She used the Japanese fear of her leprosy to listen in on battle plans, then passed the information to American forces under Douglas MacArthur. Most people with the disease have met that fear with far less reward.

    In Brazil, folklore holds that leprosy is carried by dogs, linked to sexual promiscuity, or sent as punishment for sin. Domestic workers can lose their jobs as the signs of the disease appear. In extreme cases in northern India, leprosy is equated with an untouchable status that, in one description, "often persists long after individuals with leprosy have been cured of the disease, creating lifelong prospects of divorce, eviction, loss of employment, and ostracism from family and social networks." Until 2019, a diagnosis of leprosy was legal grounds for an Indian spouse to petition for divorce. Fear of such outcomes delays people from seeking treatment, and people with leprosy face a higher risk of problems with mental well-being.

    Some lives became symbols. Baldwin IV of Jerusalem, who lived from 1161 to 1185, ruled as the "Leper King" of Latin Jerusalem. The Belgian priest Damien De Veuster caught the disease while ministering on Molokai in the Kingdom of Hawaii, where people with leprosy lived under government-sanctioned quarantine. Josephine Cafrine of Seychelles had leprosy from age 12, and her journal was published as an autobiography in 1923. The Indian actress Dimple Kapadia was diagnosed a few months before filming the 1973 musical romance Bobby, recovered completely, and built a successful career.

    Art has tried to look directly at the disease. The Iranian poet Forugh Farrokhzad made a 22-minute documentary about a leprosy colony, The House Is Black. It opens with the statement that there is no shortage of ugliness in the world, but that by closing our eyes to ugliness we will intensify it. Stephen R. Donaldson, author of The Chronicles of Thomas Covenant, drew on time in India, where his father worked at a mission for people with leprosy.

    In 2019, India reported 114,451 new cases, 57% of the world's total. The World Health Organization has kept an Expert Committee on Leprosy since 1954, the same year World Leprosy Day began. Its definition of elimination is modest on paper: fewer than one case per 10,000 people in a community.

Updated

Common questions

What causes leprosy?

Leprosy is caused by the bacteria Mycobacterium leprae and Mycobacterium lepromatosis. Gerhard Armauer Hansen identified M. leprae in Norway in 1873, and M. lepromatosis was discovered in 2008.

How is leprosy spread between people?

Leprosy likely spreads through inhaled bacilli from the nose and upper airway of an infected person, and it requires close, extensive contact. Casual contact such as shaking hands does not spread it, and 95% of people exposed never develop the disease.

Is leprosy curable?

Leprosy is curable with multidrug therapy using rifampicin, dapsone and clofazimine. Treatment lasts six months for paucibacillary leprosy and 12 months for multibacillary leprosy.

What are the first symptoms of leprosy?

The first sign of leprosy is often a pale or pink patch of skin that may be insensitive to temperature or pain. Numbness or tenderness in the hands or feet may come with it or before it.

Can armadillos and squirrels give people leprosy?

Humans can acquire leprosy from armadillos by handling them or eating their meat, though the mechanism is not fully understood. Red squirrels in Great Britain also carry the bacteria, but wild squirrels do not appear to pose a high risk to people.

Why is leprosy also called Hansen's disease?

Leprosy is called Hansen's disease after the Norwegian physician Gerhard Armauer Hansen, who discovered the causative bacterium in 1873. The name leprosy comes from the Greek word lepra, related to lepis, meaning scale.

How many people have leprosy today?

Fewer than 200,000 people had leprosy worldwide by 2020, down from 5.2 million cases in the 1980s. Most new cases occur in 14 countries, and India accounts for more than half.

All sources

201 references cited across the entry

  1. 1JournalTreatment of leprosy/Hansen's disease in the early 21st centurySophie M. Worobec — 2008
  2. 2Definition of leprosyThe Free Dictionary
  3. 3LeprosyWorld Health Organization (WHO)
  4. 4JournalTwo Cases of Leprosy in Siblings Caused by Mycobacterium lepromatosis and Review of the LiteratureSotiriou MC, Stryjewska BM, Hill C — September 2016
  5. 6BookLearning from leprosy: insight into the human innate immune responseMontoya D, Modlin RL — 2010
  6. 7BookGuidelines for the diagnosis, treatment and prevention of leprosyWorld Health Organization. Regional Office for South-East Asia — 2018
  7. 8World Leprosy DayCDC — 26 January 2018
  8. 9JournalGlobal leprosy situation, 2012August 2012
  9. 10JournalLeprosy now: epidemiology, progress, challenges, and research gapsRodrigues LC, Lockwood DN — June 2011
  10. 11NewsThe hidden suffering of India's lepersWalsh F — 31 March 2007
  11. 12NewsIgnorance breeds leper colonies in ChinaLyn TE — Independat News & Media — 13 September 2006
  12. 14BookEncyclopedia of pestilence, pandemics, and plaguesByrne JP — Greenwood Press — 2008
  13. 15NewsForgotten victims of the virusPisuthipan A — 6 July 2020
  14. 16JournalCurrent status of leprosy: epidemiology, basic science and clinical perspectivesSuzuki K, Akama T, Kawashima A, Yoshihara A, Yotsu RR, Ishii N — February 2012
  15. 19LeprologyMerriam-Webster
  16. 22BookWHO Expert Committee on Leprosy – Eighth reportWorld Health Organization (WHO) — 2012
  17. 23JournalClinical aspects of leprosyTalhari C, Talhari S, Penna GO — 2015
  18. 24BookTextbook of Orthopedics and TraumaKulkarni GS — Jaypee Brothers Publishers — 2008
  19. 26JournalLeprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Diseasede Sousa JR, Sotto MN, Simões Quaresma JA — 28 November 2017
  20. 27JournalInterventions for ulceration and other skin changes caused by nerve damage in leprosyReinar LM, Forsetlund L, Lehman LF, Brurberg KG — July 2019
  21. 29BookSherris Medical MicrobiologyMcGraw Hill — 2004
  22. 31BookBaron's Medical MicrobiologyMcMurray DN — Univ of Texas Medical Branch — 1996
  23. 32JournalUncultivable bacteria: implications and recent trends towards identificationBhattacharya S, Vijayalakshmi N, Parija SC — October 2002
  24. 33WHO Microbiology: culture in vitroWorld Health Organization (WHO)
  25. 35Loughry WJ, Truman RW, McDonough CM, Tilak MK, Garnier S, et al. (2009) "Is leprosy spreading among nine-banded armadillos in the southeastern United States?" J Wildl Dis 45: 144–52.
  26. 36JournalLeprosy in red squirrels in ScotlandMeredith A, Del Pozo J, Smith S, Milne E, Stevenson K, McLuckie J — September 2014
  27. 37Monot M, Honoré N, Garnier T, Araoz R, Coppee JY, et al. (2005). "On the origin of leprosy". Science 308: 1040–42.
  28. 38JournalOn the age of leprosyHan XY, Silva FJ — February 2014
  29. 41JournalLeprosy in pre-Norman Suffolk, UK: biomolecular and geochemical analysis of the woman from HoxneInskip S, Taylor GM, Anderson S, Stewart G — November 2017
  30. 42JournalEpidemiologic trends of leprosy for the 21st centurySchreuder PA, Noto S, Richardus JH — January 2016
  31. 43JournalAnti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysisPenna ML, Penna GO, Iglesias PC, Natal S, Rodrigues LC — May 2016
  32. 44JournalGenetic dissection of immunity in leprosyAlcaïs A, Mira M, Casanova JL, Schurr E, Abel L — February 2005
  33. 45JournalHuman immunodeficiency virus and leprosy: an updateLockwood DN, Lambert SM — January 2011
  34. 46Epidemiology of Leprosy11 February 2016
  35. 47JournalMycobacterium leprae's evolution and environmental adaptationChavarro-Portillo B, Soto CY, Guerrero MI — September 2019
  36. 48JournalLeprosy. An update: definition, pathogenesis, classification, diagnosis, and treatmentEichelmann K, González González SE, Salas-Alanis JC, Ocampo-Candiani J — September 2013
  37. 49JournalLeprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1Joel Carlos Lastória JC, Milanez Morgado de Abreu MA — Mar–Apr 2014
  38. 50JournalTreatment of leprosyLockwood DN, Kumar B — June 2004
  39. 53JournalProbable zoonotic leprosy in the southern United StatesTruman RW, Singh P, Sharma R, Busso P, Rougemont J, Paniz-Mondolfi A, Kapopoulou A, Brisse S, Scollard DM, Gillis TP, Cole ST — April 2011
  40. 54JournalGenetic Susceptibility to Leprosy-From Classic Immune-Related Candidate Genes to Hypothesis-Free, Whole Genome ApproachesCambri G, Mira MT — 20 July 2018
  41. 55BookManson's tropical diseasesCook GC — Saunders — 2009
  42. 56JournalLinkage of leprosy susceptibility to Parkinson's disease genesEllen Buschman et al. — June 2004
  43. 57JournalLeprosy: an overview of pathophysiologyBhat RM, Prakash C — 2012
  44. 58JournalImmunology of leprosyLuis Alberto Ribeiro Fróes Júnior et al. — 2022
  45. 59JournalLeprosy: clinical and immunopathological characteristicsLuis Alberto Ribeiro Fróes Júnior et al. — 2022
  46. 60JournalB-cell subsets in leprosy lesions: unraveling the complex interplayLuis Alberto Ribeiro Fróes Júnior et al. — 2025
  47. 61International Textbook of LeprosyMoschella SL, Garcia-Albea V — September 2016
  48. 63JournalPCR-based techniques for leprosy diagnosis: from the laboratory to the clinicMartinez AN, Talhari C, Moraes MO, Talhari S — April 2014
  49. 64JournalPolymerase Chain Reaction (PCR) as a Potential Point of Care Laboratory Test for Leprosy Diagnosis-A Systematic ReviewTatipally S, Srikantam A, Kasetty S — October 2018
  50. 67JournalPitfalls in the cytological classification of borderline leprosy in the Ridley-Jopling scaleSingh N, Manucha V, Bhattacharya SN, Arora VK, Bhatia A — June 2004
  51. 68JournalClassification of leprosy according to immunity. A five-group systemRidley DS, Jopling WH — 1966
  52. 69BookAndrews' Diseases of the Skin: clinical DermatologyJames WD, Berger TG, Elston DM, Odom RB — Saunders Elsevier — 2006
  53. 70NewsWhat is Leprosy?18 November 2009
  54. 71JournalLeprosy: a review of laboratory and therapeutic aspects--part 2Lastória JC, Abreu MA — 2014
  55. 72Clinical Diagnosis of LeprosyKumar, Bhushan et al. — 11 February 2016
  56. 73JournalCriteria for diagnosis of pure neural leprosyJardim MR, Antunes SL, Santos AR, Nascimento OJ, Nery JA, Sales AM, Illarramendi X, Duppre N, Chimelli L, Sampaio EP, Sarno EP — July 2003
  57. 74JournalPrimary neuritic leprosy: a reappraisal at a tertiary care hospitalMendiratta V, Khan A, Jain A — 2006
  58. 75JournalThree cases of pure neuritic (PN) leprosy at detection in which skin lesions became visible during their courseIshida Y, Pecorini L, Guglielmelli E — July 2000
  59. 76JournalNeuritic leprosy: further progression and significanceMishra B, Mukherjee A, Girdhar A, Husain S, Malaviya GN, Girdhar BK — 1995
  60. 77JournalNeuritic leprosy: epidemiology and therapeutic responsivenessTalwar S, Jha PK, Tiwari VD — September 1992
  61. 79JournalAdvances and hurdles on the way toward a leprosy vaccineDuthie MS, Gillis TP, Reed SG — November 2011
  62. 80JournalThe role of BCG in prevention of leprosy: a meta-analysisSetia MS, Steinmaus C, Ho CS, Rutherford GW — March 2006
  63. 81JournalBCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy controlMerle CS, Cunha SS, Rodrigues LC — February 2010
  64. 82JournalBCG vaccine: WHO position paper, February 2018 - RecommendationsWorld Health Organization — June 2018
  65. 83JournalLeprosy post-exposure prophylaxis: innovation and precision public healthMoraes MO, Düppre NC — January 2021
  66. 84JournalBCG: a vaccine with multiple facesYamazaki-Nakashimada MA, Unzueta A, Berenise Gámez-González L, González-Saldaña N, Sorensen RU — August 2020
  67. 85Leprosy VaccineAmerican Leprosy Missions
  68. 87JournalChina's Mars plans, leprosy vaccine and self-driving taxisSeptember 2016
  69. 88JournalA phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adultsDuthie MS, Frevol A, Day T, Coler RN, Vergara J, Rolf T, Sagawa ZK, Marie Beckmann A, Casper C, Reed SG — February 2020
  70. 89Dr. Heiser, V., An American Doctor's Odyssey. W. W. Norton & Company, 1936
  71. 90Victor G. Heiser, "Leprosy in the Philippine Islands," Public Health Report, 24 (13 August 1909)
  72. 91JournalEvolution of pediatric pharmaceutical forms for treatment of Hansen's disease (leprosy)Jocimar da Silva Santos et al. — 2 January 2023
  73. 92JournalMetabolism and interactions of antileprosy drugsGeorge J — 2020
  74. 93WHO: MDT and drug resistanceWorld Health Organization (WHO)
  75. 94JournalUpdate on the epidemiology, diagnosis, and treatment of leprosyReibel F, Cambau E, Aubry A — September 2015
  76. 95JournalThe impact of leprosy on the mental wellbeing of leprosy-affected persons and their family members - a systematic reviewSomar P, Waltz MM, van Brakel WH — 2020
  77. 96JournalA systematic review of multi-level stigma interventions: state of the science and future directionsRao D, Elshafei A, Nguyen M, Hatzenbuehler ML, Frey S, Go VF — February 2019
  78. 99Leprosy still lurks in United States, study saysMaggie Veatch — 21 February 2019
  79. 100About ILEPILEP
  80. 101BookEpidemiology of leprosy in relation to control. Report of a WHO Study Group((World Health Organization)) — World Health Organization — 1985
  81. 102Number of new leprosy casesWorld Health Organization (WHO) — 20 February 2026
  82. 103JournalOn the origin of leprosyMarc Monot et al. — 2005
  83. 105JournalAncient skeletal evidence for leprosy in India (2000 B.C.)Robbins G, Tripathy VM, Misra VN, Mohanty RK, Shinde VS, Gray KM, Schug MD — May 2009
  84. 106JournalInfection, disease, and biosocial processes at the end of the Indus CivilizationRobbins Schug G, Blevins KE, Cox B, Gray K, Mushrif-Tripathy V — December 2013
  85. 108JournalAncient genomes reveal a high diversity of Mycobacterium leprae in medieval EuropeSchuenemann VJ, Avanzi C, Krause-Kyora B, Seitz A, Herbig A, Inskip S, Bonazzi M, Reiter E, Urban C, Dangvard Pedersen D, Taylor GM, Singh P, Stewart GR, Velemínský P, Likovsky J, Marcsik A, Molnár E, Pálfi G, Mariotti V, Riga A, Belcastro MG, Boldsen JL, Nebel A, Mays S, Donoghue HD, Zakrzewski S, Benjak A, Nieselt K, Cole ST, Krause J — May 2018
  86. 109BookEtc: A Review of General SemanticsLendrum FC — Institute of General Semantics — 1954
  87. 110JournalMycobacterium leprae: A historical study on the origins of leprosy and its social stigmaSantacroce L, Del Prete R, Charitos IA, Bottalico L — 10 December 2021
  88. 111BookMedical Meanings: A Glossary of Word OriginsWilliam S. Haubrich — ACP Press — 2003
  89. 112BookThe Gospels and ActsMichael Wilkins et al. — B&H — 1 October 2013
  90. 113Skin Diseases in the Bible and the TalmudFeldheim Publishers — 2003
  91. 114BookThe Seven Books of Paulus Aegineta: Translated from the Greek with Commentary Embracing a Complete View of the Knowledge Possessed by the Greeks, Romans and Arabians on all Subjects Connected with Medicine and SurgeryFrancis Adams — Sydenham Society — 1678
  92. 115JournalOppdagelsen av leprabasillenIrgens LM — March 2002
  93. 117JournalPre-European contact leprosy in the Americas and its current persistenceMaria Lopopolo — 2025
  94. 118JournalLeprosy in New ZealandMontgomerie JZ — 1988
  95. 121JournalAlice Augusta Ball: The African-American chemist who pioneered the first viable treatment for Hansen's DiseaseSabha Mushtaq et al. — January 2023
  96. 122BookCambridge handbook of psychology, health and medicineAndrew Baum — Cambridge University Press — 1997
  97. 123JournalExperimental and clinical studies on rifampicin in treatment of leprosyRees RJ, Pearson JM, Waters MF — January 1970
  98. 124JournalOnce-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosyYawalkar SJ, McDougall AC, Languillon J, Ghosh S, Hajra SK, Opromolla DV, Tonello CJ — May 1982
  99. 125Treatment Hansen's Disease (Leprosy)Centers for Disease Control and Prevention — 22 October 2018
  100. 126Communicable Diseases Department, Leprosy FAQWorld Health Organization (WHO) — 25 May 2006
  101. 127Arch Dermato Syphilis 1898; 44:159–174
  102. 128JournalDr E W Price, the discoverer of podoconiosisVernon G — February 2022
  103. 130WHO donated MDTWorld Health Organization (WHO)
  104. 132JournalLeprosy – Hidden Disease?Singh KS, Pandey BD — March 2012
  105. 133JournalThe stigmatization of leprosy in India and its impact on future approaches to elimination and controlJacob JT, Franco-Paredes C — January 2008
  106. 134JournalLeprosy in the BibleGrzybowski A, Nita M — January 2016
  107. 135[See: Orr, James, M.A., D.D. General Editor. "Entry for 'Leper; Leprosy'". "International Standard Bible Encyclopedia". 1915. Access-date=6 January 2017
  108. 136Is Tzaraat Leprosy?Shurpin Y — 6 April 2022
  109. 137BookThe Miracles of Jesusvan der Loos H — Brill Archive — 1968
  110. 138JournalA Lesson from Leviticus: LeprosyLewis G — December 1987
  111. 140JournalRecent Perspectives on Leprosy in Medieval Western EuropeBrenner E — 2010
  112. 141JournalThe Order of Saint Lazarus and the CrusadesBarber M — July 1994
  113. 142JournalMedieval Leprosy ReconsideredMiller TS, Smith-Savage R — 2006
  114. 143BookWalking Corpses: Leprosy in Byzantium and the Medieval WestMiller TS, Nesbitt JW — Cornell University Press — 19 April 2014
  115. 144BookThe Medieval worldLe Goff J — Collins & Brown — 1990
  116. 145BookThe Mediaeval Hospitals of EnglandClay RM — Methuen & Co. — 1909
  117. 146BookMedieval English medicineRubin S — Newton Abbot: David & Charles — 1974
  118. 147Medieval Leprosy24 April 2017
  119. 148JournalPeople with leprosy (Hansen's disease) during the Middle AgesCovey HC — 1 June 2001
  120. 149BookThe Formation of a Persecuting SocietyMoore RI — Blackwell — 2007
  121. 150JournalEinige Nachrichten von den Cagots in FrankreichFranz Xaver von Zach — March 1798
  122. 151JournalThe CagotsD. Hack Tuke — Wiley — 1880
  123. 152JournalCagotsBritish Medical Journal — 11 May 1912
  124. 153BookGenetic susceptibility to leprosyAlter A. — McGill University — 2010
  125. 154Daniel Cornelius DanielssenSvein Atle Skålevåg — Store norske leksikon
  126. 155Carl Wilhelm BoeckSvein Atle Skålevåg — Store norske leksikon — 28 September 2014
  127. 156BookLeprosy, Racism, And Public Health: Social Policy In Chronic Disease ControlZachary Gussow — Routledge — 2021
  128. 157JournalGlobal leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives4 September 2020
  129. 159BookDisease: The extraordinary stories behind history's deadliest killersDobson M — Quercus Editions Ltd — 2013
  130. 160JournalCase Report of Leprosy in Central Florida, USA, 2022Aashni Bhukhan et al. — 2023
  131. 162JournalExplaining a complex disease process: talking to patients about Hansen's disease (leprosy) in BrazilWhite C — September 2005
  132. 164JournalSelf-mortification and the stigma of leprosy in northern IndiaBarrett R — June 2005
  133. 168Leprosy eliminationWorld Health Organization (WHO)
  134. 170BookThe leper king and his Heirs: Baldwin IV and the Crusader Kingdom of JerusalemHamilton, Bernard — Cambridge University Press — 2000
  135. 172BookSekigahara 1600: The Final Struggle for Power (Campaign Series, 40)Bryant A — Osprey Publishing (UK) — 1995
  136. 173BookFra gamle dage: memoarer, dagbøker, salmer og dikt av kvinner ca. 1660-1880Barbra Ring et al. — Universitetsforlaget — 1983
  137. 174BookThe Colony: The Harrowing True Story of the Exiles of MolokaiTayman J — Simon and Schuster — 2007
  138. 177NewsNation Home14 January 2016
  139. 179JournalContemporary Vietnamese WritingCung giu Nguyên — University of Oklahoma — 1955
  140. 180News5 Famous Spies Who Made Philippine HistoryLazatin H — 8 January 2018
  141. 181NewsEx-leper led bid for Culion town statusVolt Contreras — 8 May 2006
  142. 185BookSquint
  143. 187JournalLeprosy in wild armadillosTruman R — September 2005
  144. 189JournalSusceptibility and resistance in leprosy: Studies in the mouse modelL. B. Adams — 2021
  145. 190JournalThe armadillo: a model for the neuropathy of leprosy and potentially other neurodegenerative diseasesSharma R, Lahiri R, Scollard DM, Pena M, Williams DL, Adams LB, Figarola J, Truman RW — January 2013
  146. 191JournalThe pathogenesis of leprosy in the nine-banded armadillo and the significance of IgM antibodies to PGL-1Job CK, Drain V, Truman R, Deming AT, Sanchez RM, Hastings RC — April 1992
  147. 192JournalThe armadillo as a model for peripheral neuropathy in leprosyR. W. Truman et al. — 2014
  148. 195JournalLeprosy in Red Squirrels in the UKSchilling A, Del-Pozo J, Lurz PW, Stevenson K, Avanzi C, Shuttleworth CM, Cole ST, Meredith AL — 30 March 2019
  149. 197JournalReprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infectionMasaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, Rambukkana A — January 2013
  150. 199JournalIn vivo partial reprogramming by bacteria promotes adult liver organ growth without fibrosis and tumorigenesisHess S, Kendall TJ, Pena M, Yamane K, Soong D, Adams L, Truman R, Rambukkana A — November 2022
  151. 201BookCarville's Cure: Leprosy, Stigma, and the Fight for JusticePam Fessler — Liveright — 2020

Queue